Search
forLearn
5 / 801 resultslearn Epigallocatechin gallate-glucoside
learn Greyverse
learn Keraguard
learn orich-37
Research
5 / 1000+ results
research Microencapsulated cell tracking
Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.
research In VivoEvaluation ofGalla chinensisSolution in the Topical Treatment of Dermatophytosis
Galla chinensis solution effectively treats fungal skin infections in dogs.
research A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro
AD198 is more effective than doxorubicin in stopping certain dog cancer cells.
research Study on Plasma Concentration and Bioavailability of Wogonin in Beagle's Dogs
Improving wogonin's solubility greatly increases its absorption in the body.
research A Case Report: Treatment of Anaplasmosis and Ectoparasitic Infestation in Mixed-Breed Golden Retriever Dog
The dog was successfully treated for infections and parasites, improving its health and activity.
Community Join
5 / 1000+ resultscommunity Tressless ChatGPT AI is GOAT..
Minoxidil, finasteride, and RU58841 are discussed as treatments for hair loss. Users find ChatGPT a helpful tool for researching these treatments.
community When will GT20029 become available for group buy?
The conversation discusses the potential availability of GT20029 for hair loss treatment, with one user noting promising Phase 1 results and inquiring about gray market access. Another user humorously suggests it will take 50 years to become available.
community TresslessGPT is available to ChatGPT Plus users
The conversation introduces a specialized chatbot for ChatGPT Plus users that provides advice on hair loss treatments, drawing from research and community insights. It mentions treatments like RU58841, the "big 4" (likely minoxidil, finasteride, ketoconazole, and tretinoin), dutasteride mesotherapy, topical melatonin, microneedling, and rapamycin.
community GT20029 China Phase II Trial For AGA Reached Primary Endpoint
The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.
community Bad news about GT20029 from Anagen Inc
The conversation is about the difficulty in obtaining GT20029, a hair loss treatment, due to patent issues and the need to resort to group buys or Chinese labs for acquisition. Specific treatments mentioned include Minoxidil, finasteride, and RU58841.